PRELUDE CAPITAL MANAGEMENT, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2020$94,000
-17.5%
556
-43.7%
0.01%
-37.5%
Q1 2020$114,000
-82.0%
988
-82.2%
0.01%
-66.7%
Q4 2019$633,000
+17.9%
5,540
-11.9%
0.02%0.0%
Q3 2019$537,000
+2137.5%
6,285
+1845.8%
0.02%
+2300.0%
Q1 2019$24,000
+50.0%
323
+9.9%
0.00%0.0%
Q4 2017$16,000
-92.5%
294
-92.9%
0.00%
-95.0%
Q2 2017$214,000
-7.0%
4,135
+12.8%
0.02%
-9.1%
Q1 2017$230,000
+56.5%
3,665
+31.4%
0.02%
+22.2%
Q4 2016$147,000
+320.0%
2,790
+326.0%
0.02%
+350.0%
Q3 2016$35,000
+25.0%
655
-6.8%
0.00%0.0%
Q2 2016$28,000
-85.6%
703
-87.4%
0.00%
-85.2%
Q1 2016$195,000
-67.1%
5,564
-57.9%
0.03%
-70.7%
Q4 2015$593,000
+57.7%
13,224
+35.6%
0.09%
+67.3%
Q3 2015$376,000
-26.3%
9,755
-7.5%
0.06%
-22.5%
Q2 2015$510,000
+13.1%
10,541
-17.5%
0.07%
+12.7%
Q1 2015$451,000
+67.0%
12,771
+51.8%
0.06%
+57.5%
Q4 2014$270,000
-50.8%
8,413
-30.1%
0.04%
-45.9%
Q1 2014$549,000
+85.5%
12,042
+62.4%
0.07%
+51.0%
Q4 2013$296,000
+3.5%
7,417
+13.8%
0.05%
+6.5%
Q3 2013$286,000
-44.5%
6,517
-60.2%
0.05%
-58.2%
Q2 2013$515,000
-48.9%
16,356
-42.3%
0.11%
-41.5%
Q1 2013$1,007,00028,3560.19%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders